Comparison of morphological changes of rheumatoid arthritis fibroblast-like synoviocytes (RA FLSs) treated with either celecoxib or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by light microscopy (magnification × 300)
<p><b>Copyright information:</b></p><p>Taken from "Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblasts"</p><p>Arthritis Research & Therapy 2007;9(6):R128-R128.</p><p>Published online 12 Dec 2007</p><p>PMCID:PMC2246250.</p><p></p> Untreated RA FLSs (upper panel) and cells treated for either 1 hour with 60 μm celecoxib (middle panel) or 8 hours with 1 nM TRAIL (lower panel) are shown. Apoptotic cells are indicated by arrows
